These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8491226)

  • 21. Preparation of the renal function and imaging agent 99mTc-MAG3 starting from S-unprotected mercaptoacetyltriglycine.
    Noll B; Johannsen B; May K; Spies H
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):899-901. PubMed ID: 1321100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.
    Ponto JA
    Am J Hosp Pharm; 1990 Nov; 47(11):2511-3. PubMed ID: 2177584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of SepPak and high-performance liquid chromatography as techniques for measuring the radiochemical purity of 99mTc-MAG3.
    Millar AM; Hesslewood SR
    Nucl Med Commun; 2004 Oct; 25(10):1049-51. PubMed ID: 15381873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
    Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
    Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of HPLC and TLC analytical methods to determine radiochemical purity of
    Mutin J; Orhon P; Choisnard L; Lassiaz M; Bacot S; Ahmadi M; De Leiris N; Djaileb L; Broisat A; Ghezzi C; Bedouch P; Brunet MD; Leenhardt J
    J Pharm Biomed Anal; 2024 Aug; 246():116224. PubMed ID: 38759321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi).
    Hung JC; Wilson ME; Brown ML; Gibbons RJ
    J Nucl Med; 1991 Nov; 32(11):2162-8. PubMed ID: 1834815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.
    Taylor A; Eshima D; Christian PE; Wooten WW; Hansen L; McElvany K
    J Nucl Med; 1988 May; 29(5):616-22. PubMed ID: 2967353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
    Kiratli PO; Salanci BV
    J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimised quality control method for determination of the radiochemical purity of [
    Pirot C; Peyronnet D; Vigne J
    Eur J Hosp Pharm; 2024 Jun; 31(4):376-380. PubMed ID: 36690417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rapid radiochemical purity testing method for 99mTc-tetrofosmin.
    Eggert LA; Dick MD; Mahoney DW; Olson JP; Werner GL; Hung JC
    J Nucl Med Technol; 2010 Jun; 38(2):81-4. PubMed ID: 20484182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sources of radiochemical impurities in the 99mTc/S-unprotected MAG3 system.
    Noll B; Johannsen B; Spies H
    Nucl Med Biol; 1995 Nov; 22(8):1057-62. PubMed ID: 8998467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99Tcm-MAG3: in vitro stability and in vivo behaviour at different times after preparation.
    Millar AM; Wilkinson AG; McAteer E; Best JJ
    Nucl Med Commun; 1990 Jun; 11(6):405-12. PubMed ID: 2143569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine.
    Bormans G; Cleynhens B; Adriaens P; Vanbilloen H; De Roo M; Verbruggen A
    Nucl Med Biol; 1995 Apr; 22(3):339-49. PubMed ID: 7627149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid quality control for testing the radiochemical purity of 99Tc(m)-tetrofosmin.
    Métayé T; Desmarquet M; Rosenberg T; Guilhot J; Bouin-Pineau MH
    Nucl Med Commun; 2001 Oct; 22(10):1139-44. PubMed ID: 11567189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
    Millar AM
    Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of fast protein liquid chromatography as an alternative to high performance liquid chromatography of 99mTc-labelled human serum albumin preparations.
    Verbeke K; Verbruggen A
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1209-13. PubMed ID: 8818035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method.
    Paludan JP; Kraack R; Falborg L; Abrahamsen J
    Nucl Med Biol; 2022; 114-115():1-5. PubMed ID: 36087488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine determination of radiochemical purity of 99mTc-MIBI.
    Proulx A; Ballinger JR; Gulenchyn KY
    Int J Rad Appl Instrum A; 1989; 40(1):95-7. PubMed ID: 2540127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, radiochemical purity control and stability of 99mTc-mertiatide (Mag-3).
    van Hemert FJ; van Lenthe H; Schimmel KJ; van Eck-Smit BL
    Ann Nucl Med; 2005 Jun; 19(4):345-9. PubMed ID: 16097648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.